LON:VAL

ValiRx Share Forecast, Price & News

GBX 18.32

-1.18 (-6.04 %)

(As of 06/15/2021 04:29 PM ET)

Add

Compare

Today's Range

17.80

▼

19.45

50-Day Range

18.01

▼

22.50

52-Week Range

6.65

▼

Volume802,888 shs

Average Volume768,002 shs

Market Capitalization£11.92 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive VAL News and Ratings via Email

Sign-up to receive the latest news and ratings for ValiRx and its competitors with MarketBeat's FREE daily newsletter.

About ValiRx

ValiRx plc, a biotechnology oncology focused company, engages in developing novel therapeutics and associated biomarkers for cancer in the United Kingdom. The company's lead drug candidates include VAL201, an anti-cancer therapeutic that is in Phase I/II trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth, including endometriosis; VAL301, a reformulation of VAL201, which is in pre-clinical development for the treatment of women with endometriosis; and VAL401, a reformulation of generic drug Risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL101, a candidate produced by GeneICE technology platform to modulate BCl2 expression Â- implicated in cancers. ValiRx plc has collaboration agreement with Oncolytika Limited and Black Cat Bio Limited to develop and evaluate BC201 for patients suffering a hyperimmune response to Coronavirus SARS-CoV2 infection. The company was incorporated in 2000 and is based in Hatfield, the United Kingdom.

TRADING UPDATES: Brave Bison, Strix Group see strong performances - Morningstar
May 27, 2021 | morningstar.co.uk

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo - Morningstar
April 28, 2021 | morningstar.co.uk

TRADING UPDATES: Focusrite sales soar; Gaming... - Morningstar
April 27, 2021 | morningstar.co.uk

Are Insiders Buying ValiRx plc (LON:VAL) Stock?
February 23, 2021 | finance.yahoo.com

What's Hot from Sept. 21st #MONY #TEK #IAG #WTB #VAL
September 22, 2020 | lse.co.uk

ValiRx plc (VAL.L)
August 14, 2020 | uk.finance.yahoo.com

Valirx Share News (VAL)
June 8, 2020 | www.lse.co.uk

BRIEF-ValiRx Plc Says Suzanne Dilly Has Been Appointed As A Director Of Co
June 8, 2020 | www.reuters.com

BRIEF-ValiRx Intends To Appoint Kevin Cox As Non-Executive Chairman
May 28, 2020 | www.reuters.com

BRIEF-ValiRx Announces Conditional Fundraise Of £1.2 Million
May 5, 2020 | www.reuters.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolLON:VAL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.valirx.com
Phone+44-20-30084416
Employees11
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowGBX 3.21 per share
Price / Cash Flow5.70
Book ValueGBX 8.50 per share
Price / Book2.16

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares65,049,000
Market Cap£11.92 million
Next Earnings Date6/28/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.34 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ValiRx.

1.7 Community Rank

Outperform Votes
ValiRx has received 150 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ValiRx has received 282 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ValiRx has received 65.28% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ValiRx and other stocks. Vote “Outperform” if you believe VAL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VAL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ValiRx does not currently pay a dividend.
Dividend Growth
ValiRx does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ValiRx insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of ValiRx is -4.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ValiRx is -4.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ValiRx has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

ValiRx (LON:VAL) Frequently Asked Questions

What stocks does MarketBeat like better than ValiRx?

Wall Street analysts have given ValiRx a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ValiRx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is ValiRx's next earnings date?

ValiRx is scheduled to release its next quarterly earnings announcement on Monday, June 28th 2021.
View our earnings forecast for ValiRx.

How were ValiRx's earnings last quarter?

ValiRx plc (LON:VAL) issued its quarterly earnings results on Monday, September, 7th. The company reported ($4.43) earnings per share (EPS) for the quarter.
View ValiRx's earnings history.

How has ValiRx's stock been impacted by COVID-19?

ValiRx's stock was trading at GBX 0.05 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VAL stock has increased by 40,615.6% and is now trading at GBX 18.32.
View which stocks have been most impacted by COVID-19.

Who are ValiRx's key executives?

ValiRx's management team includes the following people:

Mr. James Gerry Desler, CFO & Exec. Director (Age 65, Pay $52.89k)
Mr. Kevin J. Alexander, Sec. & Independent Non-Exec. Director (Age 65, Pay $25.62k)
Dr. Suzanne J. Dilly B.Sc., BSc, Ph.D., CEO & Director (Age 43)
Mr. Kumar Nawani, Head of Operations
Mr. Tarquin Edwards, Head of Investor Relations & Communications
Mr. Mark Treharne, Corp. Devel. Mang.

Who are some of ValiRx's key competitors?

Some companies that are related to ValiRx include Oxford BioDynamics (OBD), 4basebio UK Societas (4BB), Tissue Regenix Group (TRX), Hvivo (HVO), OptiBiotix Health (OPTI), IXICO (IXI), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), Fusion Antibodies (FAB), Rua Life Sciences (RUA), IntelGenx Technologies (IGX), Collagen Solutions plc (COS.L) (COS), Biopharmx (BPMX), AorTech International (AOR) and Quest PharmaTech (QPT).
View all of VAL's competitors.

What other stocks do shareholders of ValiRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ValiRx investors own include Petrofac (PFC), boohoo group (BOO), ReNeuron Group (RENE), Falanx Group (FLX), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), IQE (IQE), Lloyds Banking Group (LLOY), Eckoh (ECK) and Sareum (SAR).

What is ValiRx's stock symbol?

ValiRx trades on the London Stock Exchange (LON) under the ticker symbol "VAL."

How do I buy shares of ValiRx?

Shares of VAL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ValiRx's stock price today?

One share of VAL stock can currently be purchased for approximately GBX 18.32.

How much money does ValiRx make?

ValiRx has a market capitalization of £11.92 million.

How many employees does ValiRx have?

ValiRx employs 11 workers across the globe.

What is ValiRx's official website?

The official website for ValiRx is www.valirx.com.

Where are ValiRx's headquarters?

ValiRx is headquartered at 3rd Fl, 16 Upper Woburn Place, LONDON, WC1H 0BS, United Kingdom.

How can I contact ValiRx?

ValiRx's mailing address is 3rd Fl, 16 Upper Woburn Place, LONDON, WC1H 0BS, United Kingdom. The company can be reached via phone at +44-20-30084416.

This page was last updated on 6/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

ValiRx Share Forecast, Price & News

About ValiRx

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

1.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth